Board approved the scheme of amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited being wholly owned subsidiaries with Meghmani Organics Limited.
M&A
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 04 Apr 2026, 02:13 PM IST · BSE ID: 4510225e-3b85-40f8-adcc-4c88c56bef42
View Original BSE Filing (PDF)
💡
In Simple Terms
The parent company is merging two of its subsidiary companies into itself to simplify operations and improve efficiency.
🤖 AI Summary
- Board approved amalgamation scheme for Kilburn Chemicals and Meghmani Crop Nutrition into Meghmani Organics
- Combined transferor company assets Rs. 77,349.77 Lakhs; transferee company assets Rs. 309,525.53 Lakhs as of 31.12.2025
- Appointed date January 1, 2026; scheme effective upon NCLT order filing with Registrar of Companies
- Related party transaction undertaken at arm's length basis per Companies Act 2013 compliance
- Pending approvals: NCLT order, shareholder consent, creditor sanction, regulatory clearances
🔢 Key Numbers — exact figures from BSE filing, not rounded
Kilburn Chemicals Limited — Total Assets (31.12.2025)
Rs. 65,709.14 Lakhs
Kilburn Chemicals Limited — Total Turnover (31.12.2025)
Rs. 4,976.00 Lakhs
Meghmani Crop Nutrition Limited — Total Assets (31.12.2025)
Rs. 11,640.63 Lakhs
Meghmani Crop Nutrition Limited — Total Turnover (31.12.2025)
Rs. 2,523.12 Lakhs
Meghmani Organics Limited — Total Assets (31.12.2025)
Rs. 309,525.53 Lakhs
Meghmani Organics Limited — Total Turnover (31.12.2025)
Rs. 163,519.67 Lakhs
Scheme Appointed Date
1 January 2026
🏢 How This Affects the Company
Consolidation integrates Titanium Dioxide manufacturing and crop nutrition businesses into parent entity. Eliminates subsidiary layer, streamlining product portfolio under single legal entity with combined annual turnover of Rs. 7,499.12 Lakhs from transferor companies.
Balance sheet consolidates Rs. 77,349.77 Lakhs of subsidiary assets into parent balance sheet (Rs. 309,525.53 Lakhs as of 31.12.2025). No cash outflow required for acquisition as subsidiaries already wholly owned.
All employees, contracts, licenses, and obligations of Kilburn Chemicals and Meghmani Crop Nutrition transfer to parent company. Single unified operational structure replaces subsidiary management layers, reducing administrative overhead.
Scheme completion contingent on NCLT approval and creditor/shareholder sanction. Regulatory delays or opposition would defer integration benefits. Combined entity concentration in pigments and crop protection expands exposure to agricultural and pigments sectors.
👥 What This Means For Shareholders
✅
Action Required
Parent company shareholders must attend extraordinary general meeting and approve scheme per SEBI and Companies Act requirements when convened.
👤
Who Is Affected
All Meghmani Organics Limited shareholders approve amalgamation. Subsidiary shareholders (wholly owned by parent) experience no dilution. Subsidiary creditors must consent to debt transfer to parent entity.
🔍
Management Signal
Consolidation strategy prioritizes operational simplification and group efficiency over subsidiary autonomy, signaling intent to streamline multi-entity structure into unified legal entity.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
NCLT petition filing and scheduled hearing date for scheme approval order issuance
Extraordinary general meeting notice for shareholder approval of amalgamation scheme
Regulation 31A(10) filing confirming NCLT order certified copy filed with Registrar of Companies—execution effective date
MEDIUM RISK
Scheme approval requires multi-layer regulatory clearance (NCLT, shareholders, creditors). Delays or opposition to any approval would defer consolidation. No financial risk quantified in filing.
💡 Investor Takeaway
Board approved amalgamation of Rs. 77,349.77 Lakhs (combined assets) of subsidiaries into parent company. Appointed date January 1, 2026. Execution requires NCLT order, shareholder, and creditor approvals. Scheme treats transaction at arm's length per Companies Act compliance.
⚖️ Strengths & Concerns
✅ Positives
- Wholly owned subsidiaries eliminate external shareholders — internal consolidation streamlines governance and reduces transaction friction
- Appointed date backdated to 1 January 2026 ensures accounting continuity and simplifies financial reporting for calendar year 2026
⚠️ Concerns
- Scheme remains subject to NCLT approval and creditor sanction — regulatory delays could defer execution beyond current timeline
- Smaller subsidiary turnover (Rs. 4,976 Lakhs and Rs. 2,523.12 Lakhs) indicates limited scale contribution to parent's Rs. 163,519.67 Lakhs annual turnover
📅 Company Track Record
Past filing 31-03-2026 indicated Board meeting scheduled for 04-04-2026 to consider amalgamation scheme; deal terms undisclosed at that stage. Current filing confirms Board approval of scheme; execution contingent on regulatory approvals.
Based on publicly available historical data. For context only.